Advanced Enzyme Technologies Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹203.37 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.27 per cent from ₹171.95 crore. This corresponds to a year-on-year *(YoY) growth of 21.65 per cent.
Operating Profit
Operating Profit stands at ₹63.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.13 per cent from ₹49.35 crore. This corresponds to a year-on-year *(YoY) growth of 38.66 per cent.
PBDT
PBDT stands at ₹69.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.18 per cent from ₹68.50 crore. This corresponds to a year-on-year *(YoY) growth of 30.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹59.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.59 per cent from ₹58.29 crore. This corresponds to a year-on-year *(YoY) growth of 37.60 per cent.
Net Profit
Net Profit stands at ₹45.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.79 per cent from ₹43.18 crore. This represents a 69.29 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Advanced Enzyme Technologies Ltd Earnings
- YOY
- QOQ
Advanced Enzyme Technologies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Advanced Enzyme Technologies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Advanced Enzyme Technologies Ltd Financial Reports
Advanced Enzyme Technologies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Advanced Enzyme | -2.54% | -2.70% | 13.47% | 24.71% | 19.58% | 30.09% |
| FDC | 2.87% | 2.95% | 1.18% | 2.33% | -10.74% | -18.54% |
| Senores Pharma. | 0.04% | 5.13% | 18.37% | 43.71% | 42.71% | 120.22% |
| Innova Captab | -2.87% | -2.94% | 17.87% | 25.71% | 16.11% | -2.39% |
| Guj. Themis Bio. | 3.32% | 4.03% | 3.48% | 17.75% | -11.50% | 18.13% |
| RPG LifeScience. | 0.75% | 0.11% | 14.39% | 20.31% | 2.91% | 6.60% |
| Orchid Pharma | 0.85% | -3.78% | 21.03% | 12.50% | -19.00% | -4.45% |
Company Info
Company Information
Whole-time director : MUKUND MADHUSUDAN KABRA
Chairman (Non-Executive) : VASANT RATHI
Independent Director : Pramod Kasat
Company Sec. & Compli. Officer : Sanjay Basantani
Non-Executive & Non-Independent Director : Rasika Rathi
Independent Director : Vindokumar Hiralal Jajoo
Non-Executive & Non-Independent Director : Sunny Sharma
Independent Director : Rajshree Patel
Independent Director : NITIN JAGANNATH DESHMUKH
Independent Director : Vandana Tilak.